tradingkey.logo


tradingkey.logo


ImageneBio Ord Shs

IMA
5.120USD
-0.280-5.19%
終倀 03/30, 16:00ET15分遅れの株䟡
20.59M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 䌁業名

ImageneBio Ord Shsの䌁業情報


䌁業コヌド- -
䌚瀟名- -
䞊堎日- -
最高経営責任者「CEO」- -
埓業員数- -
蚌刞皮類- -
決算期末- -
本瀟所圚地- -
郜垂- -
蚌刞取匕所- -
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌド- -
䞊堎日- -
最高経営責任者「CEO」- -

ImageneBio Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Kristin Yarema, Ph.D.
Dr. Kristin Yarema, Ph.D.
Chief Executive Officer, Interim Principal Financial Officer, Director
Chief Executive Officer, Interim Principal Financial Officer, Director
85.40K
--
Ms. Erin Butler
Ms. Erin Butler
Senior Vice President - Finance, Administration
Senior Vice President - Finance, Administration
25.55K
+88.06%
Mr. Joseph P. Slattery
Mr. Joseph P. Slattery
Director
Director
16.00K
--
Dr. Yufang Lu, M.D., Ph.D.
Dr. Yufang Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Kristin Yarema, Ph.D.
Dr. Kristin Yarema, Ph.D.
Chief Executive Officer, Interim Principal Financial Officer, Director
Chief Executive Officer, Interim Principal Financial Officer, Director
85.40K
--
Ms. Erin Butler
Ms. Erin Butler
Senior Vice President - Finance, Administration
Senior Vice President - Finance, Administration
25.55K
+88.06%
Mr. Joseph P. Slattery
Mr. Joseph P. Slattery
Director
Director
16.00K
--
Dr. Yufang Lu, M.D., Ph.D.
Dr. Yufang Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--

収益内蚳

FY2025Q3
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
0.00
0.00%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Fri, Mar 20
曎新時刻: Fri, Mar 20
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Engene Inc
9.12%
OrbiMed Advisors, LLC
8.53%
Blue Owl Capital Holdings LP
7.73%
BVF Partners L.P.
7.53%
Cable Car Capital LLC
6.04%
他の
61.05%
株䞻統蚈
株䞻統蚈
比率
Engene Inc
9.12%
OrbiMed Advisors, LLC
8.53%
Blue Owl Capital Holdings LP
7.73%
BVF Partners L.P.
7.53%
Cable Car Capital LLC
6.04%
他の
61.05%
皮類
株䞻統蚈
比率
Investment Advisor
13.08%
Investment Advisor/Hedge Fund
11.30%
Hedge Fund
11.07%
Corporation
10.78%
Private Equity
8.53%
Venture Capital
5.16%
Individual Investor
5.05%
Research Firm
0.38%
他の
34.64%

機関投資家保有株


曎新時刻: Wed, Jan 21
曎新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q4
69
4.75M
31.23%
--
2025Q4
143
5.39M
50.65%
+1.65M
2025Q3
149
4.75M
44.63%
+904.63K
2025Q2
149
2.80M
80.96%
-570.89K
2025Q1
150
2.82M
81.38%
-1.12M
2024Q4
149
3.19M
92.09%
+164.51K
2024Q3
156
2.55M
73.79%
-1.03M
2024Q2
156
3.25M
94.96%
-481.24K
2024Q1
143
3.36M
98.10%
-401.43K
2023Q4
138
3.53M
103.06%
+553.39K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Engene Inc
971.17K
9.12%
+971.17K
--
Sep 08, 2025
OrbiMed Advisors, LLC
378.56K
3.55%
--
--
Sep 30, 2025
Blue Owl Capital Holdings LP
540.92K
5.08%
+200.00K
+58.66%
Sep 30, 2025
BVF Partners L.P.
802.10K
7.53%
+468.22K
+140.24%
Sep 30, 2025
Omega Fund Management, LLC
455.36K
4.28%
+267.93K
+142.95%
Sep 30, 2025
RTW Investments L.P.
334.44K
3.14%
+334.44K
--
Sep 30, 2025
Wang (Stephen Hui)
250.72K
2.35%
+250.72K
--
Sep 08, 2025
The Vanguard Group, Inc.
233.36K
2.19%
+115.55K
+98.09%
Sep 30, 2025
Bristol Myers Squibb
177.76K
1.67%
+177.76K
--
Sep 30, 2024
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 9
曎新時刻: Tue, Dec 9
銘柄名
比率
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
比率0.01%
Dimensional US Core Equity 1 ETF
比率0%
iShares Russell 2000 ETF
比率0%
Global X Russell 2000 Covered Call ETF
比率0%
ProShares UltraPro Russell2000
比率0%
ProShares Hedge Replication ETF
比率0%
iShares Russell 2000 Value ETF
比率0%
Global X Russell 2000 ETF
比率0%
Proshares Ultra Russell 2000
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Jul 15, 2025
Merger
12→1
日付
配圓萜ち日
皮類
比率
Jul 15, 2025
Merger
12→1
KeyAI
î™